Psychemedics Corp. · OTC:PMDI

Psychemedics — Investor Presentation (March 2022)

11 slides from Psychemedics's investor presentation, March 2022

  1. Slide 1: Psychemedics: Superior Science. Superior Results.

    PSYCHEMEDICS Superior Science. Superior Results. P

  2. Slide 2: Safe Harbor Statement

    Safe Harbor Statement This presentation contains forward-looking information that involves risks and uncertainties, including statements about the Company’s prospects, the Company’s financial performance, targets, goals, and metrics, participation in multiple markets, its technology and research and

  3. Slide 3: Psychemedics Overview

    Psychemedics Overview Founded in 1986, Psychemedics is the world’s largest provider of hair analysis drug testing, using a best-in-class analysis to test for drugs of abuse • Re-invented the drug testing industry with patented technology that extracts virtually 100% of the drug held in hair to be an

  4. Slide 4: Key Investment Highlights

    Key Investment Highlights The Pioneer and Industry Leader with Opportunities for Growth World’s largest provider of hair testing, re-inventing the industry, providing superior in-depth analysis and unmatched insights for clients, while expanding into new market segments and additional tests Changing

  5. Slide 5: Changing Market Dynamics Increasingly Favor Psychemedics Hair Testing

    Changing Market Dynamics Increasingly Favor Psychemedics Hair Testing Urine and Saliva are the least effective matrices at detecting drugs of abuse SAN FRANCISCO, May 31, 2021 /PRNewswire/ -- While the majority of employers use urine: The global drug testing market size is expected to • The most dan

  6. Slide 6: Compelling Value Proposition: All Hair Testing is NOT the Same

    Compelling Value Proposition backed by Psychemedics patented technology All Hair Testing is NOT the Same Drug Use in the Workplace is Costly Substantial Cost Reduction • Drug use in the workplace costs employers approximately • A drug abuser costs their employer an average of (1) $120bn annually in

  7. Slide 7: Marquee Customer Base

    Marquee Customer Base Psychemedics provides hair drug testing to thousands of clients in a wide range of industries Proprietary hair analysis technology is trusted by a wide, diverse range of the worlds most recognized corporate clients, plus schools, law enforcement and parents Blue Chip Customer B

  8. Slide 8: Unique Technology: All Hair Testing is NOT the Same

    Unique Technology: All Hair Testing is NOT the Same The Company utilizes its proprietary drug extraction method followed by a unique enzyme immunoassay (EIA) to identify drug use in hair Other Hair Urinalysis Window of Detection 90 Days 90 Days 1-3 Days for most drugs Only lab with FDA 510(k) cleara

  9. Slide 9: Our Superior Detection Of All Drugs Is Our Powerful Deterrent To Usage

    Our Superior Detection Of All Drugs Is Our Powerful Deterrent To Usage Superior Detection Superior Protection Superior Deterrence Identifies more users of more drugs Detects more of the most dangerous drugs Declining positive rates over time A large trucking firm identified 900 drug Psychemedics del

  10. Slide 10: Positive, Lasting Social Impact

    Positive, Lasting Social Impact There is a growing crisis in the workplace as employee drug abuse is accelerating and causing loss of productivity and increased injuries. Reducing these financial and human costs requires unparalleled drug testing accuracy and deterrence that only Psychemedics can pr

  11. Slide 11: Psychemedics

    PSYCHEMEDICS Superior Science. Superior Results. P

Psychemedics — Investor Presentation (March 2022) on 6ix